CAC1C_MOUSE - dbPTM
CAC1C_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CAC1C_MOUSE
UniProt AC Q01815
Protein Name Voltage-dependent L-type calcium channel subunit alpha-1C
Gene Name Cacna1c
Organism Mus musculus (Mouse).
Sequence Length 2139
Subcellular Localization Membrane
Multi-pass membrane protein . Cell membrane . The interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane.
Protein Description Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1C gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA (omega-Aga-IIIA). They are however insensitive to omega-conotoxin-GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA). Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart. The various isoforms display marked differences in the sensitivity to DHP compounds. Binding of calmodulin or CABP1 at the same regulatory sites results in opposite effects on the channel function..
Protein Sequence MVNENTRMYVPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTPGAALSWQAAIDAARQAKLMGSAGNATISTVSSTQRKRQQYGKPKKQGGTTATRPPRALLCLTLKNPIRRACISIVEWKPFEIIILLTIFANCVALAIYIPFPEDDSNATNSNLERVEYLFLIIFTVEAFLKVIAYGLLFHPNAYLRNGWNLLDFIIVVVGLFSAILEQATKADGANALGGKGAGFDVKALRAFRVLRPLRLVSGVPSLQVVLNSIIKAMVPLLHIALLVLFVIIIYAIIGLELFMGKMHKTCYNQEGIIDVPAEEDPSPCALETGHGRQCQNGTVCKPGWDGPKHGITNFDNFAFAMLTVFQCITMEGWTDVLYWMQDAMGYELPWVYFVSLVIFGSFFVLNLVLGVLSGEFSKEREKAKARGDFQKLREKQQLEEDLKGYLDWITQAEDIDPENEDEGMDEDKPRNMSMPTSETESVNTENVAGGDIEGENCGARLAHRISKSKFSRYWRRWNRFCRRKCRAAVKSNVFYWLVIFLVFLNTLTIASEHYNQPHWLTEVQDTANKALLALFTAEMLLKMYSLGLQAYFVSLFNRFDCFIVCGGILETILVETKIMSPLGISVLRCVRLLRIFKITRYWNSLSNLVASLLNSVRSIASLLLLLFLFIIIFSLLGMQLFGGKFNFDEMQTRRSTFDNFPQSLLTVFQILTGEDWNSVMYDGIMAYGGPSFPGMLVCIYFIILFICGNYILLNVFLAIAVDNLADAESLTSAQKEEEEEKERKKLARTASPEKKQEVMEKPAVEESKEEKIELKSITADGESPPTTKINMDDLQPSENEDKSPHSNPDTAGEEDEEEPEMPVGPRPRPLSELHLKEKAVPMPEASAFFIFSPNNRFRLQCHRIVNDTIFTNLILFFILLSSISLAAEDPVQHTSFRNHILGNADYVFTSIFTLEIILKMTAYGAFLHKGSFCRNYFNILDLLVVSVSLISFGIQSSAINVVKILRVLRVLRPLRAINRAKGLKHVVQCVFVAIRTIGNIVIVTTLLQFMFACIGVQLFKGKLYTCSDSSKQTEAECKGNYITYKDGEVDHPIIQPRSWENSKFDFDNVLAAMMALFTVSTFEGWPELLYRSIDSHTEDKGPIYNYRVEISIFFIIYIIIIAFFMMNIFVGFVIVTFQEQGEQEYKNCELDKNQRQCVEYALKARPLRRYIPKNQHQYKVWYVVNSTYFEYLMFVLILLNTICLAMQHYGQSCLFKIAMNILNMLFTGLFTVEMILKLIAFKPKGYFSDPWNVFDFLIVIGSIIDVILSETNPAEHTQCSPSMSAEENSRISITFFRLFRVMRLVKLLSRGEGIRTLLWTFIKSFQALPYVALLIVMLFFIYAVIGMQVFGKIALNDTTEINRNNNFQTFPQAVLLLFRCATGEAWQDIMLACMPGKKCAPESEPSNSTEGETPCGSSFAVFYFISFYMLCAFLIINLFVAVIMDNFDYLTRDWSILGPHHLDEFKRIWAEYDPEAKGRIKHLDVVTLLRRIQPPLGFGKLCPHRVACKRLVSMNMPLNSDGTVMFNATLFALVRTALRIKTEGNLEQANEELRAIIKKIWKRTSMKLLDQVVPPAGDDEVTVGKFYATFLIQEYFRKFKKRKEQGLVGKPSQRNALSLQAGLRTLHDIGPEIRRAISGDLTAEEELDKAMKEAVSAASEDDIFRRAGGLFGNHVTYYQSDSRGNFPQTFATQRPLHINKTGNNQADTESPSHEKLVDSTFTPSSYSSTGSNANINNANNTALGRFPHPAGYSSTVSTVEGHGPPLSPAVRVQEAAWKLSSKRCHSRESQGATVNQEIFPDETRSVRMSEEAEYCSEPSLLSTDMFSYQEDEHRQLTCPEEDKREIQPSPKRSFLRSASLGRRASFHLECLKRQKDQGGDISQKTALPLHLVHHQALAVAGLSPLLQRSHSPTTFPRPCPTPPVTPGSRGRPLRPIPTLRLEGAESSEKLNSSFPSIHCSSWSEETTACSGSSSMARRARPVSLTVPSQAGAPGRQFHGSASSLVEAVLISEGLGQFAQDPKFIEVTTQELADACDMTIEEMENAADNILSGGAQQSPNGTLLPFVNCRDPGQDRAVAPEDESCAYALGRGRSEEALADSRSYVSNL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
63UbiquitinationIDAARQAKLMGSAGN
HHHHHHHHHHCCCCC
30.57-
72PhosphorylationMGSAGNATISTVSST
HCCCCCCEEEECCCH
21.3326239621
77PhosphorylationNATISTVSSTQRKRQ
CCEEEECCCHHHHHH
27.9623737553
78PhosphorylationATISTVSSTQRKRQQ
CEEEECCCHHHHHHH
24.9923737553
79PhosphorylationTISTVSSTQRKRQQY
EEEECCCHHHHHHHH
25.5323737553
106S-palmitoylationRPPRALLCLTLKNPI
CCCCEEEHHCCCCHH
2.5828680068
153N-linked_GlycosylationPFPEDDSNATNSNLE
CCCCCCCCCCCCHHH
58.75-
171PhosphorylationYLFLIIFTVEAFLKV
HHHHHHHHHHHHHHH
13.66-
328N-linked_GlycosylationGHGRQCQNGTVCKPG
CCCCCCCCCCCCCCC
56.58-
469PhosphorylationRNMSMPTSETESVNT
CCCCCCCCCCCCCCC
36.3322817900
471PhosphorylationMSMPTSETESVNTEN
CCCCCCCCCCCCCCC
33.0722817900
473PhosphorylationMPTSETESVNTENVA
CCCCCCCCCCCCCCC
28.2519060867
476PhosphorylationSETESVNTENVAGGD
CCCCCCCCCCCCCCC
27.1222817900
783PhosphorylationKKLARTASPEKKQEV
HHHHHHCCHHHHHHH
32.7416155576
808PhosphorylationEEKIELKSITADGES
HHCEEEEEEECCCCC
37.4822817900
810PhosphorylationKIELKSITADGESPP
CEEEEEEECCCCCCC
26.2822807455
815PhosphorylationSITADGESPPTTKIN
EEECCCCCCCCCCCC
41.5325521595
818PhosphorylationADGESPPTTKINMDD
CCCCCCCCCCCCHHH
44.0723737553
819PhosphorylationDGESPPTTKINMDDL
CCCCCCCCCCCHHHC
35.3823737553
829PhosphorylationNMDDLQPSENEDKSP
CHHHCCCCCCCCCCC
39.8425338131
835PhosphorylationPSENEDKSPHSNPDT
CCCCCCCCCCCCCCC
39.9221082442
838PhosphorylationNEDKSPHSNPDTAGE
CCCCCCCCCCCCCCC
54.1425338131
842PhosphorylationSPHSNPDTAGEEDEE
CCCCCCCCCCCCCCC
37.5121082442
1184UbiquitinationYKNCELDKNQRQCVE
HHCCCCCHHHHHHHH
68.55-
1388N-linked_GlycosylationVFGKIALNDTTEINR
HHHHHHCCCCCCCCC
35.24-
1439N-linked_GlycosylationAPESEPSNSTEGETP
CCCCCCCCCCCCCCC
64.76-
1487PhosphorylationDYLTRDWSILGPHHL
HHHHCCCHHCCHHHH
16.5420479240
1509UbiquitinationAEYDPEAKGRIKHLD
HHCCHHCCCCCCCHH
47.24-
1545PhosphorylationVACKRLVSMNMPLNS
HHHHHHHHCCCCCCC
14.7220479240
1635AcetylationFRKFKKRKEQGLVGK
HHHHHHHHHHCCCCC
64.3711789845
1642UbiquitinationKEQGLVGKPSQRNAL
HHHCCCCCHHHHHHH
33.73-
1644PhosphorylationQGLVGKPSQRNALSL
HCCCCCHHHHHHHHH
45.3027742792
1650PhosphorylationPSQRNALSLQAGLRT
HHHHHHHHHHHHHHH
18.9423737553
1670PhosphorylationPEIRRAISGDLTAEE
HHHHHHHCCCCCHHH
25.8526824392
1674PhosphorylationRAISGDLTAEEELDK
HHHCCCCCHHHHHHH
36.4427742792
1688PhosphorylationKAMKEAVSAASEDDI
HHHHHHHHHHCCCHH
25.7622324799
1691PhosphorylationKEAVSAASEDDIFRR
HHHHHHHCCCHHHHH
41.0725521595
1714PhosphorylationVTYYQSDSRGNFPQT
EEEEECCCCCCCCCC
47.5422817900
1733PhosphorylationRPLHINKTGNNQADT
CCCEECCCCCCCCCC
40.4229899451
1740PhosphorylationTGNNQADTESPSHEK
CCCCCCCCCCCCCCH
41.1829899451
1742PhosphorylationNNQADTESPSHEKLV
CCCCCCCCCCCCHHH
33.5225521595
1744PhosphorylationQADTESPSHEKLVDS
CCCCCCCCCCHHHCC
54.2623737553
1756PhosphorylationVDSTFTPSSYSSTGS
HCCCCCCCCCCCCCC
38.5625338131
1763PhosphorylationSSYSSTGSNANINNA
CCCCCCCCCCCCCCC
32.6225338131
1799PhosphorylationEGHGPPLSPAVRVQE
CCCCCCCCHHHHHHH
19.3129514104
1812PhosphorylationQEAAWKLSSKRCHSR
HHHHHHHHCCCCCCC
30.0425338131
1818PhosphorylationLSSKRCHSRESQGAT
HHCCCCCCCCCCCCC
41.1729899451
1821PhosphorylationKRCHSRESQGATVNQ
CCCCCCCCCCCCCCC
32.5729899451
1835PhosphorylationQEIFPDETRSVRMSE
CHHCCCCCCCCCCCH
35.3130635358
1889PhosphorylationPKRSFLRSASLGRRA
CCHHHHHHHHCCHHH
25.10-
1897PhosphorylationASLGRRASFHLECLK
HHCCHHHHHHHHHHH
16.047814415
1978PhosphorylationLRLEGAESSEKLNSS
EEECCCCCHHHHHHC
43.1726824392
1979PhosphorylationRLEGAESSEKLNSSF
EECCCCCHHHHHHCC
30.2023737553
2015PhosphorylationARRARPVSLTVPSQA
HCCCCCEEEECCCCC
22.4726824392
2020PhosphorylationPVSLTVPSQAGAPGR
CEEEECCCCCCCCCC
28.46-
2034PhosphorylationRQFHGSASSLVEAVL
CCCCCCHHHHHHHHH
26.3825338131
2035PhosphorylationQFHGSASSLVEAVLI
CCCCCHHHHHHHHHH
35.8325338131
2125PhosphorylationYALGRGRSEEALADS
HHCCCCCCHHHHHHC
42.4826824392

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
783SPhosphorylationKinaseCDK5P49615
PSP
1487SPhosphorylationKinaseCAMK2AQ9UQM7
PSP
1487SPhosphorylationKinaseCAMK2AP11798
PSP
1545SPhosphorylationKinaseCAMK2AQ9UQM7
PSP
1545SPhosphorylationKinaseCAMK2AP11798
PSP
1644SPhosphorylationKinasePRKCAP17252
GPS
1897SPhosphorylationKinasePKACAP17612
PSP
1897SPhosphorylationKinasePRKACAP27791
GPS
1897SPhosphorylationKinasePRKCAP17252
GPS
1897SPhosphorylationKinasePKA-FAMILY-GPS
1897SPhosphorylationKinasePKA-Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
1897SPhosphorylation

25368181

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CAC1C_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TRI13_MOUSETrim13physical
21186355
RYR2_MOUSERyr2physical
16352659
CACB3_MOUSECacnb3physical
16787652
IL16_MOUSEIl16physical
10479680

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CAC1C_MOUSE

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Qualitative and quantitative analyses of protein phosphorylation innaive and stimulated mouse synaptosomal preparations.";
Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,Gerrits B., Panse C., Schlapbach R., Mansuy I.M.;
Mol. Cell. Proteomics 6:283-293(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-815, AND MASSSPECTROMETRY.

TOP